URGN - Wutah bathi EPS kuartalan UroGen Pharma

Tandha merek UroGen Pharma (URGN)

UroGen Pharma Ltd. (URGN) is transitioning from the research phase to expanding its commercial presence in urological oncology. Business growth is driven by the success of Jelmyto and the approval of UGN-102, while maintaining strict cost controls. The implementation of unique long-acting drugs ensures stability. The quarterly EPS growth rate on GURU.Markets reflects profit dynamics, where the current figure is 95.10.

URGN: Wutah bathi EPS kuartalan UroGen Pharma 04.07.2022 - 17.11.2026

Rincian analitis perusahaan UroGen Pharma Ltd.

- nilai pasar lan prakiraan target analis:
Analisis fundamental perusahaan:urogen.com - URGN
Produk asil prodhuksi UroGen Pharma Corp

Quarterly EPS growth reflects the dynamics of net income per share, measuring the efficiency of capital generation for shareholders. This metric is calculated as the percentage change in earnings between the current period and the same period last year. By analyzing the quarterly EPS growth vector, an investor determines the business's operational turnaround phase. For UroGen Pharma Ltd. (URGN), this indicator marks the success of innovations in uro-oncology. High expenditures on scientific personnel and achievement bonuses directly impact the final profitability.

Analisis perusahaan pesaing

ONC: Wutah bathi EPS kuartalan|Halozyme Inc. - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|RVMD (Revolution Medicines Inc) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Ascentage Pharma Group AAPG|Wutah bathi EPS kuartalan CGON|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan BCAX (Bicara Therapeutics)|Wutah bathi EPS kuartalan PSNL (personalis.com)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ERAS|DCTH - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Y-mAbs Therapeutics (YMAB) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|AURA: Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan CADL|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Accuray Inc.|SELLAS Life Sciences Group (SLS) - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan ACTU (Actuate Therapeutics, Inc)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan Citius Oncology|TuHURA Biosciences, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan Protara TARA|fatetherapeutics.com - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Aadi Bioscience|TCRX: Wutah bathi EPS kuartalan|CSBR - Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|XBIT (XBiotech) - Wutah bathi EPS kuartalan|CVM: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan OSTX|RADX (Radiopharm Theranostics Limited) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ARTV (Artiva Biotherapeutics, Inc.)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ANL|VERU: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|TPST - Wutah bathi EPS kuartalan|XLO (xiliotx.com) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Renovaro Biosciences - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan MURA|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan KAPA|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan OKUR (OnKure Therapeutics Inc)|Wutah bathi EPS kuartalan CytoMed (GDTC)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan curis.com CRIS|APLM (Apollomics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Tharimmune Corporation - Wutah bathi EPS kuartalan|ADVB (advanbiomed.com) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|Genprex, Inc (GNPX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|CLDI: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|SBFM (Sunshine Biopharma, Inc.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan XBIO (Xenetic Biosciences)|Wutah bathi EPS kuartalan SLRX|Purple Biotech - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|American Oncology Network - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan BGNE|CKPT - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Elevation Oncology (ELEV) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|ICAD: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Ikena Oncology Inc.|NTBL (Notable Labs Ltd) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Viracta Therapeutics (VIRX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan AAPGV (Ascentage)